Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetic acid salicyloyl-amino-ester is a synthetic small molecule belonging to the class of salicylamides, which are carboxamide derivatives of salicylic acid. Its molecular formula is C9H9NO4 and it has a molecular weight of 195.17 g/mol[1][2][5]. The compound is primarily studied as an experimental agent and not approved for clinical use. It acts as an inhibitor of prostaglandin G/H synthase 1 (COX‑1), thereby reducing the synthesis of prostaglandins involved in inflammation and pain signaling[1][3][4]. This mechanism suggests potential anti-inflammatory activity, though it has not been developed or approved for any therapeutic indication. The compound may also possess antioxidant properties and can alter cell permeability in biological assays[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetic acid salicyloyl-amino-ester.